好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Acute Ischemic Stroke Incidence and Characteristics After Cardiac Arrest
Neuro Trauma and Critical Care
P7 - Poster Session 7 (5:00 PM-6:00 PM)
7-005

To describe the incidence and characteristics of acute ischemic stroke in cardiac arrest patients.

Brain injury is the leading cause of death and disability post-cardiac arrest, and hypoxic-ischemic brain injury (HIBI) severity is associated with poor outcomes. There is limited information about the co-occurrence of acute ischemic stroke and its impact on outcome.

We performed a structured MRI review of a retrospective multicenter cohort of cardiac arrest patients. We included MRIs performed within 7 days from arrest and excluded traumatic brain injury, intracranial hemorrhage, and ischemic stroke at admission. Univariate and multivariable analyses were performed to explore the characteristics of cerebral infarctions and their association with poor outcomes (i.e., Cerebral Performance Category of 3-5).

Among 351 included patients, 107 had cerebral infarction based on MRI (30.5%). The most common pattern of stroke is multifocal small embolic (61.7%), followed by punctate (28.9%), watershed (7.48%), territorial (6.5%), and lacunar (2.8%). The patients with acute ischemic stroke are older (p<0.01). Chronic white matter disease was associated with the occurrence of acute ischemic stroke (odds ratio [OR] 1.89 [1.11-3.25], P<0.05). In univariate and multivariable analysis, the presence of acute ischemic stroke is not associated with poor outcomes. Worse outcome is associated with older age (OR 1.05 [1.02-1.08], P<0.001) and presence of HIBI (OR 4.37 [1.9-10.5], P<0.001).

Acute ischemic stroke is common after cardiac arrest. Acute infarctions after arrest are associated with chronic white matter disease. The most common pattern is multifocal embolic, possibly due to cardioembolism and hypercoagulable state. The impact of cerebral infarctions on cardiac arrest survivors requires deeper investigation in future longitudinal studies.

Authors/Disclosures
Marina T. Marques, MD
PRESENTER
The institution of Miss Marques has received research support from American Heart Association.
Kevin Bao Mr. Bao has nothing to disclose.
Benjamin J. Meyer, MD (University of Chicago) No disclosure on file
Matheus Otero, MD (Mount Sinai West) Dr. Otero has nothing to disclose.
Gerardo H. Velasquez Mr. Velasquez has nothing to disclose.
Parker Houston, BS Mr. Houston has nothing to disclose.
Katherine Peterson Ms. Peterson has nothing to disclose.
Claude Hemphill III, MD, FAAN (Zuckerberg San Francisco General Hospital) Dr. Hemphill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Hemphill has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Aurenar. Dr. Hemphill has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Hemphill has received research support from NIH/NINDS.
xiao hu, PhD Dr. hu has nothing to disclose.
Gisele Silva Gisele Silva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Gisele Silva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UNIFESP/HIAE.
M. B. Westover, MD, PhD (MGH) Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Jong W. Lee, MD, PhD (Brigham and Women's Hospital) The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from UCB. Dr. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Contract work with Teladoc.
Edilberto Amorim, MD The institution of Dr. Amorim has received research support from American Heart Association. The institution of Dr. Amorim has received research support from Society of Critical Care Medicine. The institution of Dr. Amorim has received research support from Zoll Foundation. The institution of Dr. Amorim has received research support from Hellman Foundation. The institution of Dr. Amorim has received research support from Regents of the University of California. The institution of Dr. Amorim has received research support from Citizens United Against Epilepsy. The institution of Dr. Amorim has received research support from Regents of the University of California. The institution of Dr. Amorim has received research support from American Heart Association. The institution of Dr. Amorim has received research support from NIH. The institution of Dr. Amorim has received research support from Department of Defense. The institution of Dr. Amorim has received research support from Department of Defense. The institution of Dr. Amorim has received research support from American Heart Association.